CA1327401C - Liver function testing apparatus - Google Patents
Liver function testing apparatusInfo
- Publication number
- CA1327401C CA1327401C CA000582563A CA582563A CA1327401C CA 1327401 C CA1327401 C CA 1327401C CA 000582563 A CA000582563 A CA 000582563A CA 582563 A CA582563 A CA 582563A CA 1327401 C CA1327401 C CA 1327401C
- Authority
- CA
- Canada
- Prior art keywords
- specific dye
- blood
- testing apparatus
- liver function
- function testing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4222—Evaluating particular parts, e.g. particular organs
- A61B5/4244—Evaluating particular parts, e.g. particular organs liver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
Abstract
ABSTRACT OF THE DISCLOSURE
In a liver function testing apparatus, light sources expose vital tissue to a first light of a wavelength capable of being absorbed by a specific dye dosed into blood of the vital tissue to be taken in and removed by the liver, and a second light of a wavelength not capable of being absorbed by the specific dye. Optical pulses obtained from the vital tissue are received by a light receiving element, the output of which is sampled by an A/D converter for converting the analog output signals into digital signals. A biocalibration is performed on the basis of variable components in the blood. For this purpose a CPU determines coefficients for first and second regression line expressions before and after an injection of the specific dye. The coefficients are provided by first and second photoelectric conversion signals. A value correlated with a specific dye concentration in the blood is processed on the basis of sampling signals during a prescribed period after injection of the specific dye to provide the coefficients for the regression line expressions. The obtained coefficients are processed by using the method of least squares for obtaining a blood plasma disappearance rate of the specific dye and a retention rate for a prescribed length of time following an injection.
In a liver function testing apparatus, light sources expose vital tissue to a first light of a wavelength capable of being absorbed by a specific dye dosed into blood of the vital tissue to be taken in and removed by the liver, and a second light of a wavelength not capable of being absorbed by the specific dye. Optical pulses obtained from the vital tissue are received by a light receiving element, the output of which is sampled by an A/D converter for converting the analog output signals into digital signals. A biocalibration is performed on the basis of variable components in the blood. For this purpose a CPU determines coefficients for first and second regression line expressions before and after an injection of the specific dye. The coefficients are provided by first and second photoelectric conversion signals. A value correlated with a specific dye concentration in the blood is processed on the basis of sampling signals during a prescribed period after injection of the specific dye to provide the coefficients for the regression line expressions. The obtained coefficients are processed by using the method of least squares for obtaining a blood plasma disappearance rate of the specific dye and a retention rate for a prescribed length of time following an injection.
Description
The present invention relates to a liver function - testing apparatus, and more specifically, it relates to a liver function testing apparatus for automatically performing measurements for testing/diagnosing a liver function by injecting a specific color dye into the patient's bloodstream, which is selectively taken in and removed only by the liver. A blood plasma disappearance rate and a retention rate are determined.
In general, the blood plasma disappearance rate and the retention rate have been measured by a method of blood collection through use of indocyanine green (hereinafter referred to as ICG) serving as specific dye.
According to this method, an intravenous injection of ICG
is given to a testee and blood collections are made three times after lapses of five, ten and fifteen minutes after the injection, and blood serum is separated upon coagulation of a blood clot so that an absorhance at a . wavelength of 805 nm is measured through a spectrophotometer to obtain ICG concentration values in the blood serum after the lapses of five, ten and fifteen minutes from a previously obtained calibration curve representing an ICG concentration in blood as a function of absorbance. Thus, it is possible to calculate the blood plasma disappearance rate and the retention rate. In recent years, a method of changing the quantity of the ICG
injection to measure the blood plasma disappearance rate several times has been widely used for obtaining an index ;`~.'4 expressing an amount of hepatic cell function R~ (removal maximal).
,. .
Japanese Patent Publication Gazette No. 58649/1985 has already proposed a method of measuring the blood plasma disappearance rate and the retention rate without - performing any blood collection. According to this method, - light is applied through the body surface of an organism, which in turn transmits light of a wavelength having a high ICG absorption sensitivity and light of a wavelength having substantially no ICG absorption sensitivity. The ' ' ' i .
.
, 132740~
respective quantities of transmitted light are measured to obtain the blood plasma disappearance rate and the retention rate as a function of elapsed time (dye disappearance curve) of the light quantities.
S In the aforementioned first mentioned method requiring the collection of blood samples, it is necessary to correctly measure the blood collection time after injection. However, the time cannot be accurately measured in fact, and the practical measuring of the index expressing the amount of hepatic cell function R~ has been complicated in its adaptation to the theory. Further, the testee has been subjected to heavy mental and physical burdens by the repeated taking of blood samples. In ~; addition, the index R~ method of measuring the blood plasma disappearance rate several times by changing the quantity of ICG injection requires the taking of more than ten blood samples, whereby the burdens on the testee are further increased.
According to the second mentioned measuring method which does not require the taking of any blood samples disclosed in Japanese Patent Publication Gazette No.
58649/1985, the output of a sensor actually attached to an organism, fluctuates under the influence of such facts as blood flow disturbances caused by a compression on a blood vessel, vibrations of the organism that is tested, ~ pulsations in the organism, changes in the blood volume in ;: the vital tissue. The blood volume in each part of a vital tissue changes due to movements, for example, by merely vertically moving an arm, etc., whereby a correct dye disappearance curve cannot be obtained. Consequently, the blood plasma disappearance rate and the retention rate obtained by the curve cannot be recognized as being correct.
Accordingly, a main object of the present invention is to provide a liver function testing apparatus which can avoid the adverse effects of the above mentioned fluctuating influences, such as blood flow disturbances, , ~
; , . _ -.. .
., ., ~
vibrations of an organism, pulsations in the organism, andchanges of the blood volume in the organism, to enable a correct measurement.
According to the present invention, there is ~- 5 provided a liver function testing apparatus for testing liver function, comprising: light source means for exposing vital tissue to a first light signal capable of being absorbed by a specific dye injected into blood of . said vital tissue, said dye to be taken in and removed by ~10 the liver, and to a second light signal capable of being : absorbed by said specific dye, photoelectric conversion means for outputting first and second photoelectric conversion signals obtained from said vital tissue and corresponding to said first light signal and to said second light signal applied to said vital tissue by said light source means, sampling means for sampling said first and second photoelectric conversion signals a plurality of times, first decision means for determining a first : coefficient of a first regression line expression between - 20 said first and second photoelectric conversion signals on the basis of variable components in said blood included in ~isaid first and second photoelectric conversion signals sampled by said sampling means a plurality of times before .injection of said specific dye, second decision means for .25 determining a second coefficient of a second regression line expression between said first and second photoelectric conversion signals on the basis of variable components in said blood included in said first and second photoelectric conversion signals sampled by said sampling means a plurality of times after a lapse of a prescribed period, and arithmetic means for storing a plurality of sampling .~signal outputs of said sampling means during a prescribed :period of time following said injection of said specific dye for processing a value correlated with a specific dye concentration in said blood on the basis of said first and second coefficients of said first and second regression line expressions determined by said first and second . ",~
.
;
-~- 1327401 decision means for obtaining a coefficient of a simulation function as a function of time by using the method of least : squares on the basis of said processed value correlated : with said specific dye concentration, for obtaining a blood plasma disappearance rate of said specific dye and a retention rate of said specific dye in said prescribed ~ period of time on the basis of said simulation function:~ coefficient.
Thus, according to the present invention, the correct time management of the disappearance curves of the . specific dye makes it possible to obtain correct data.
.:: Further, the blood plasma disappearance rate and the:-~ retention rate can be obtained without the need for taking several blood samples as is the case in the conventional blood correction method. Rather, the invention uses a large number of data obtained from the disappearance curves, thereby improving the reliability of the data.
` In a preferred embodiment of the present invention, the second coefficient is obtained within a prescribed period of time following an injection of the i.~ specific dye and allowing for an arbitrary short period ~. after a time to permit the specific dye to be uniformly i~ distributed in the blood.
Further, first dimensionless constants Al and Bl . 25 are obtained by performing a regression line analysis in ,i accordance with the following operation expression:
;'' :................................ logCLI = Al~logC~ I Bl ,,, wherein CLI and CL2 represent average voltage values of . first and second photoelectric conversion signals caused by .~ the applied first and second light quantities Ll and L2 and : sampled a plurality of times before injection of the specific dye.
: 35 Second dimensionless constants A2 and B2 are obtained by performing a regression line analysis in -.~ accordance with the following operation expression:
..;
`.. ,~. .
`'' ', , ' ,:
, .
' ' .
1~27401 :: 5 logCL~ logC~, + s2 wherein CLI. and CL2. represent average voltage values of the :; first and second photoelectric conversion signals caused by the ~pplied first and second light quantities L, and L2 and sampled a plurality of times after a lapse of a prescribed "period of time following the injection of the specific dye, . whereby ';
10log~lO = ~AI~B2 - ~ B~ A~
is obtained as a blood free point. Al, A2, B1, and B2are the ;.............above-mentioned dimensionless constants determined, as to A1 and B~, prior to the dye injection and, as to A2 and B2, after the dye injection.
. These and other objects, features, aspects and : advantages of the present invention will become more ~- apparent from the following detailed description of the ; present invention when taken in conjunction with the accompanying drawings.
, Figures 1 to 4 are diagrams for illustrating the - principle of biocalibration employed in the present invention;
Figure 5 is a schematic block diagram showing the . 25 entire structure of an embodiment of the present invention;
Figure 6 is a timing chart for detecting quantities of light of wavelength ~l and ~2 after passage through a prescribed optical path in a reference object;
: Figure 7 illustrates data stored in a RAM as shown in Figure 5;
~ Figures 8A to 8D are flow charts for concretely :;: illustrating the operation of the embodiment, in which ~ Figure 8A shows a data sampling subroutine, Figure 8B shows a biocalibration mode, Figure 8C shows an initialization : 35 mode and Figure 8D shows a measurement mode;
Figures 9 to 12 are illustrative of exemplary : displays on a display part or screen as shown in Figure 5;
.
' :
, .s ,~, : ,.
: ,., ., '~ .
. .' .
~ ~1327401 ` Figure 13 shows an example of a disappearance-curve of a specific dye measured according to the present invention;
Figure 14A illustrates a relationship between a disappearance curve, a blood plasma disappearance rate and a 1s-minute retention rate measured according to the ' present invention;
Figure 14B illustrates light values Ll and L2 measured according to the present invention and two calibration curves; and ~, Figure 15 illustrates light values Ll and L2 measured according to the present invention.
Before explaining embodiments of the present - invention, the principle of biocalibration employed in the present invention will first be explained.
Figures 1 to 4 are diagrams for illustrating the principle of the biocalibration in the present invention.
It is assumed that symbols I1 and I2 indicate quantities of light having a wavelength ~I which is largely ` 20 absorbed by the specific dye, and light of a wavelength ~2 which is not absorbed by the specific dye incident upon vital tissue. The symbols Ll and L2 indicate the above mentioned light quantities after passage through a ;` prescribed optical path in the vital tissue. Relationships ; 25 between the incident light quantities Il and I2 and the passing light quantities Ll and L2 with reference to the , injected specific dye, are as follows:
,~ "
(1) logII/LI = kgl-Cg-Vb ~ f1tCb, Vb) I ~t (2~ logI2/L2= f2(Cb, Vb) ~ ~t2 , Respective coefficients and variables are shown in Figure 1. Symbols fl and f2 represent functions which are - determined by blood characteristics at the wavelengths and ~2 On the other hand, relationships between the incident light quantities Il and I2 and the passing light ~ ' ' " ' .
.
,"~
~ ' ~ . . . .
- - . . . ;.......... ~
.... . . . .
:
`- 1327~01 quantities Ll and ~ before the injection of the specific dye are as follows:
(33 logI1/LI = fl(Cb,Vb) ~ ~t1 ~4) logI2/L2 = f2(Cb, Vb) + ~t2 :~ 5 The relationships between the passing light quantities Ll and ~ prior to an actual injection of the specific dye is measured and shown in Figure 2, whereby a logarithmic plotting provides a linear relationship as ~ 10 shown in Figure 3. The shown data represents the case of '~ attaching a sensor to an organism and fluctuating the blood ' volume in the organism. It has been confirmed that such ,~ linearity has reproducibility with no individual differences.
Then, the expressions (3) and (4) would appear as follows, as expressed by a straight line ~ shown in Figure , 4:
,,, (5) logLI = AllogL2+ B
.~ 20 ~ That is, the same can be expressed as follows, by .~ using the expressions (3) and (4):
(6) logII--{fl(Cb, Vb) + ~tl}
-~. 25 = AtlogI2 ~ {f2(Cb, Vb) + ~t2}] + B
.' where Cb represents a blood concentration in a sample and Vb represents a blood volume in the sample.
~ A function C obtained by multiplying the : 30 concentration of the specific dye by the blood volume in " the ~ample and the absorption coefficient of the specific ~, dye, by using the expressions (1) and (2) after injection of the specific dye can be expressed as follows:
, ~ 35 (7) C = logLI - [A log~2 + B]
. ~
~, .
, ~
., 5~,'~ .
' . .~
'' '" .' . ~ .
'',' .~ j.: I ' ` ` 132740~
The function C as defined by the expression (7) is then written as follows:
.; i , ; ~8) c ~ logII - kg cg Vb - {fl ~Cb, Vb) I ~t~}
--A~logI2--{f2~Cb, vb) + ~t2}~--B
., .
-~i Through the expression (6) we have:
;,.;, ~., ~; ~9) C = - kg Cg Vb ''' 10 Hence, it is understood that a signal of the `'. ''1 .~ function C can be obtained by using Figure 3 as a ;~ calibration curve.
.
As to the function C, however, although the coefficient kg is constant, it can bs considered that the blood volume Vb in each part is changed from time to time, and hencej if the blood volume Vb in a sample generated by the sensor attached to the vital tissue, is changed, the 1 amount of the specific dye is also changed in proportion to - 20 the change in the blood volume, so that the dye concentration remains unchanged. This is typically shown in Figure 4.
Referring to Figure 4, a straight line 0 represents a calibration curve before an injection of the specific dye, while another straight line ~ represents a calibration curve taken at an arbitrary short time period ~i` after an injection of the specific dye. The straight line provides calibration for a short time period, and hence the specific dye is taken to be constant. The straight line ~, considered similarly to the expression (5), is :, expressed as follows:
. ........................................................................ .
, logLI = A2- logI~2 ~ B2 The intersection 0 of the straight lines 0 and is considered to be an ischemic point at which there is .. . .
,; .
i ..
... ....
., , j.
:, , :: .
g substantially no blood in the tissue. This bloodless point is expressed as follows:
'.~
~ logL~0 = tA1-B2 - A2 B~ AI ~ A2) .'., From Figure 4 it is seen that GR/CD = OG/OC = OE/OA = EG/AC, and . ~
; GH/EG = CD/AC.
~ 10 ~-; Hence, ., .
~ kg Cg Vbl/Vbl = ~g Cg Vb2/Vb2 ., .
~ 15 Thus, .,.
G~/EG = kg Cg = CD/AC
'. .
whereby the dye concentration in the blood can be measured.
Normalizing as Y-axis logLIO of the intersection 0 between the straight lines 0 and ~, the blood volume Vb is expressed as follows:
~: `
(10) Vb = 1 ~ logL1O - (Al logL2 ~ B
< 25 logL~0 ., , Hence, a signal Cg corresponding to a voltage `:;! representing the specific dye concentration, can be found by the expressions (7) and (10) as follows:
~ 30 t` tll) Cg = logLIO-tlogLlO - (Al-logL2 + Bl)]
In general, the blood plasma disappearance rate and the retention rate have been measured by a method of blood collection through use of indocyanine green (hereinafter referred to as ICG) serving as specific dye.
According to this method, an intravenous injection of ICG
is given to a testee and blood collections are made three times after lapses of five, ten and fifteen minutes after the injection, and blood serum is separated upon coagulation of a blood clot so that an absorhance at a . wavelength of 805 nm is measured through a spectrophotometer to obtain ICG concentration values in the blood serum after the lapses of five, ten and fifteen minutes from a previously obtained calibration curve representing an ICG concentration in blood as a function of absorbance. Thus, it is possible to calculate the blood plasma disappearance rate and the retention rate. In recent years, a method of changing the quantity of the ICG
injection to measure the blood plasma disappearance rate several times has been widely used for obtaining an index ;`~.'4 expressing an amount of hepatic cell function R~ (removal maximal).
,. .
Japanese Patent Publication Gazette No. 58649/1985 has already proposed a method of measuring the blood plasma disappearance rate and the retention rate without - performing any blood collection. According to this method, - light is applied through the body surface of an organism, which in turn transmits light of a wavelength having a high ICG absorption sensitivity and light of a wavelength having substantially no ICG absorption sensitivity. The ' ' ' i .
.
, 132740~
respective quantities of transmitted light are measured to obtain the blood plasma disappearance rate and the retention rate as a function of elapsed time (dye disappearance curve) of the light quantities.
S In the aforementioned first mentioned method requiring the collection of blood samples, it is necessary to correctly measure the blood collection time after injection. However, the time cannot be accurately measured in fact, and the practical measuring of the index expressing the amount of hepatic cell function R~ has been complicated in its adaptation to the theory. Further, the testee has been subjected to heavy mental and physical burdens by the repeated taking of blood samples. In ~; addition, the index R~ method of measuring the blood plasma disappearance rate several times by changing the quantity of ICG injection requires the taking of more than ten blood samples, whereby the burdens on the testee are further increased.
According to the second mentioned measuring method which does not require the taking of any blood samples disclosed in Japanese Patent Publication Gazette No.
58649/1985, the output of a sensor actually attached to an organism, fluctuates under the influence of such facts as blood flow disturbances caused by a compression on a blood vessel, vibrations of the organism that is tested, ~ pulsations in the organism, changes in the blood volume in ;: the vital tissue. The blood volume in each part of a vital tissue changes due to movements, for example, by merely vertically moving an arm, etc., whereby a correct dye disappearance curve cannot be obtained. Consequently, the blood plasma disappearance rate and the retention rate obtained by the curve cannot be recognized as being correct.
Accordingly, a main object of the present invention is to provide a liver function testing apparatus which can avoid the adverse effects of the above mentioned fluctuating influences, such as blood flow disturbances, , ~
; , . _ -.. .
., ., ~
vibrations of an organism, pulsations in the organism, andchanges of the blood volume in the organism, to enable a correct measurement.
According to the present invention, there is ~- 5 provided a liver function testing apparatus for testing liver function, comprising: light source means for exposing vital tissue to a first light signal capable of being absorbed by a specific dye injected into blood of . said vital tissue, said dye to be taken in and removed by ~10 the liver, and to a second light signal capable of being : absorbed by said specific dye, photoelectric conversion means for outputting first and second photoelectric conversion signals obtained from said vital tissue and corresponding to said first light signal and to said second light signal applied to said vital tissue by said light source means, sampling means for sampling said first and second photoelectric conversion signals a plurality of times, first decision means for determining a first : coefficient of a first regression line expression between - 20 said first and second photoelectric conversion signals on the basis of variable components in said blood included in ~isaid first and second photoelectric conversion signals sampled by said sampling means a plurality of times before .injection of said specific dye, second decision means for .25 determining a second coefficient of a second regression line expression between said first and second photoelectric conversion signals on the basis of variable components in said blood included in said first and second photoelectric conversion signals sampled by said sampling means a plurality of times after a lapse of a prescribed period, and arithmetic means for storing a plurality of sampling .~signal outputs of said sampling means during a prescribed :period of time following said injection of said specific dye for processing a value correlated with a specific dye concentration in said blood on the basis of said first and second coefficients of said first and second regression line expressions determined by said first and second . ",~
.
;
-~- 1327401 decision means for obtaining a coefficient of a simulation function as a function of time by using the method of least : squares on the basis of said processed value correlated : with said specific dye concentration, for obtaining a blood plasma disappearance rate of said specific dye and a retention rate of said specific dye in said prescribed ~ period of time on the basis of said simulation function:~ coefficient.
Thus, according to the present invention, the correct time management of the disappearance curves of the . specific dye makes it possible to obtain correct data.
.:: Further, the blood plasma disappearance rate and the:-~ retention rate can be obtained without the need for taking several blood samples as is the case in the conventional blood correction method. Rather, the invention uses a large number of data obtained from the disappearance curves, thereby improving the reliability of the data.
` In a preferred embodiment of the present invention, the second coefficient is obtained within a prescribed period of time following an injection of the i.~ specific dye and allowing for an arbitrary short period ~. after a time to permit the specific dye to be uniformly i~ distributed in the blood.
Further, first dimensionless constants Al and Bl . 25 are obtained by performing a regression line analysis in ,i accordance with the following operation expression:
;'' :................................ logCLI = Al~logC~ I Bl ,,, wherein CLI and CL2 represent average voltage values of . first and second photoelectric conversion signals caused by .~ the applied first and second light quantities Ll and L2 and : sampled a plurality of times before injection of the specific dye.
: 35 Second dimensionless constants A2 and B2 are obtained by performing a regression line analysis in -.~ accordance with the following operation expression:
..;
`.. ,~. .
`'' ', , ' ,:
, .
' ' .
1~27401 :: 5 logCL~ logC~, + s2 wherein CLI. and CL2. represent average voltage values of the :; first and second photoelectric conversion signals caused by the ~pplied first and second light quantities L, and L2 and sampled a plurality of times after a lapse of a prescribed "period of time following the injection of the specific dye, . whereby ';
10log~lO = ~AI~B2 - ~ B~ A~
is obtained as a blood free point. Al, A2, B1, and B2are the ;.............above-mentioned dimensionless constants determined, as to A1 and B~, prior to the dye injection and, as to A2 and B2, after the dye injection.
. These and other objects, features, aspects and : advantages of the present invention will become more ~- apparent from the following detailed description of the ; present invention when taken in conjunction with the accompanying drawings.
, Figures 1 to 4 are diagrams for illustrating the - principle of biocalibration employed in the present invention;
Figure 5 is a schematic block diagram showing the . 25 entire structure of an embodiment of the present invention;
Figure 6 is a timing chart for detecting quantities of light of wavelength ~l and ~2 after passage through a prescribed optical path in a reference object;
: Figure 7 illustrates data stored in a RAM as shown in Figure 5;
~ Figures 8A to 8D are flow charts for concretely :;: illustrating the operation of the embodiment, in which ~ Figure 8A shows a data sampling subroutine, Figure 8B shows a biocalibration mode, Figure 8C shows an initialization : 35 mode and Figure 8D shows a measurement mode;
Figures 9 to 12 are illustrative of exemplary : displays on a display part or screen as shown in Figure 5;
.
' :
, .s ,~, : ,.
: ,., ., '~ .
. .' .
~ ~1327401 ` Figure 13 shows an example of a disappearance-curve of a specific dye measured according to the present invention;
Figure 14A illustrates a relationship between a disappearance curve, a blood plasma disappearance rate and a 1s-minute retention rate measured according to the ' present invention;
Figure 14B illustrates light values Ll and L2 measured according to the present invention and two calibration curves; and ~, Figure 15 illustrates light values Ll and L2 measured according to the present invention.
Before explaining embodiments of the present - invention, the principle of biocalibration employed in the present invention will first be explained.
Figures 1 to 4 are diagrams for illustrating the principle of the biocalibration in the present invention.
It is assumed that symbols I1 and I2 indicate quantities of light having a wavelength ~I which is largely ` 20 absorbed by the specific dye, and light of a wavelength ~2 which is not absorbed by the specific dye incident upon vital tissue. The symbols Ll and L2 indicate the above mentioned light quantities after passage through a ;` prescribed optical path in the vital tissue. Relationships ; 25 between the incident light quantities Il and I2 and the passing light quantities Ll and L2 with reference to the , injected specific dye, are as follows:
,~ "
(1) logII/LI = kgl-Cg-Vb ~ f1tCb, Vb) I ~t (2~ logI2/L2= f2(Cb, Vb) ~ ~t2 , Respective coefficients and variables are shown in Figure 1. Symbols fl and f2 represent functions which are - determined by blood characteristics at the wavelengths and ~2 On the other hand, relationships between the incident light quantities Il and I2 and the passing light ~ ' ' " ' .
.
,"~
~ ' ~ . . . .
- - . . . ;.......... ~
.... . . . .
:
`- 1327~01 quantities Ll and ~ before the injection of the specific dye are as follows:
(33 logI1/LI = fl(Cb,Vb) ~ ~t1 ~4) logI2/L2 = f2(Cb, Vb) + ~t2 :~ 5 The relationships between the passing light quantities Ll and ~ prior to an actual injection of the specific dye is measured and shown in Figure 2, whereby a logarithmic plotting provides a linear relationship as ~ 10 shown in Figure 3. The shown data represents the case of '~ attaching a sensor to an organism and fluctuating the blood ' volume in the organism. It has been confirmed that such ,~ linearity has reproducibility with no individual differences.
Then, the expressions (3) and (4) would appear as follows, as expressed by a straight line ~ shown in Figure , 4:
,,, (5) logLI = AllogL2+ B
.~ 20 ~ That is, the same can be expressed as follows, by .~ using the expressions (3) and (4):
(6) logII--{fl(Cb, Vb) + ~tl}
-~. 25 = AtlogI2 ~ {f2(Cb, Vb) + ~t2}] + B
.' where Cb represents a blood concentration in a sample and Vb represents a blood volume in the sample.
~ A function C obtained by multiplying the : 30 concentration of the specific dye by the blood volume in " the ~ample and the absorption coefficient of the specific ~, dye, by using the expressions (1) and (2) after injection of the specific dye can be expressed as follows:
, ~ 35 (7) C = logLI - [A log~2 + B]
. ~
~, .
, ~
., 5~,'~ .
' . .~
'' '" .' . ~ .
'',' .~ j.: I ' ` ` 132740~
The function C as defined by the expression (7) is then written as follows:
.; i , ; ~8) c ~ logII - kg cg Vb - {fl ~Cb, Vb) I ~t~}
--A~logI2--{f2~Cb, vb) + ~t2}~--B
., .
-~i Through the expression (6) we have:
;,.;, ~., ~; ~9) C = - kg Cg Vb ''' 10 Hence, it is understood that a signal of the `'. ''1 .~ function C can be obtained by using Figure 3 as a ;~ calibration curve.
.
As to the function C, however, although the coefficient kg is constant, it can bs considered that the blood volume Vb in each part is changed from time to time, and hencej if the blood volume Vb in a sample generated by the sensor attached to the vital tissue, is changed, the 1 amount of the specific dye is also changed in proportion to - 20 the change in the blood volume, so that the dye concentration remains unchanged. This is typically shown in Figure 4.
Referring to Figure 4, a straight line 0 represents a calibration curve before an injection of the specific dye, while another straight line ~ represents a calibration curve taken at an arbitrary short time period ~i` after an injection of the specific dye. The straight line provides calibration for a short time period, and hence the specific dye is taken to be constant. The straight line ~, considered similarly to the expression (5), is :, expressed as follows:
. ........................................................................ .
, logLI = A2- logI~2 ~ B2 The intersection 0 of the straight lines 0 and is considered to be an ischemic point at which there is .. . .
,; .
i ..
... ....
., , j.
:, , :: .
g substantially no blood in the tissue. This bloodless point is expressed as follows:
'.~
~ logL~0 = tA1-B2 - A2 B~ AI ~ A2) .'., From Figure 4 it is seen that GR/CD = OG/OC = OE/OA = EG/AC, and . ~
; GH/EG = CD/AC.
~ 10 ~-; Hence, ., .
~ kg Cg Vbl/Vbl = ~g Cg Vb2/Vb2 ., .
~ 15 Thus, .,.
G~/EG = kg Cg = CD/AC
'. .
whereby the dye concentration in the blood can be measured.
Normalizing as Y-axis logLIO of the intersection 0 between the straight lines 0 and ~, the blood volume Vb is expressed as follows:
~: `
(10) Vb = 1 ~ logL1O - (Al logL2 ~ B
< 25 logL~0 ., , Hence, a signal Cg corresponding to a voltage `:;! representing the specific dye concentration, can be found by the expressions (7) and (10) as follows:
~ 30 t` tll) Cg = logLIO-tlogLlO - (Al-logL2 + Bl)]
2 logLIO - (Al logL2 I Bl) Using the method of least squares, the above expression for Cg can be expressed as a simulation curve plotted over time. The simulation curve is expressed as follows:
., ~; ~12) Cg = Ae-B~
:~ .
... .
. ,. . ~
1~27401 . 10 wherein t represents the elapsed time after injection of the specific dye and symbols A and B represent constants.
-` The constants A and B are found by the above expression (12). The blood plasma disappearance rate k and the retention rate R % are expressed as follows:
~13) k = B
(14) R % = e -BT
:, wherein T represents the elapsed time in minutes after injection of the dye. These two rates characteristically express the intake of the specific dye into the liver.
Since the retention rate applies to an elapsed time of T
~` minutes, this retention rate may be referred to as the "T-: 15 minute retention rate".
While the biocalibration employed in the present ` invention has been described above, an embodiment of the ~ present invention employing the aforementioned ; biocalibration will now be described.
Figure 5 is a schematic block diagram showing an ~ embodiment of the present invention, Figure 6 is a timing i chart for detecting quantities of light of wavelengths ~
and ~2 after passage through a prescribed optical path through a measured object, and Figure 7 illustrates data stored in a RAM as shown in Figure 5.
Referring to Figure 5, the present liver function testing apparatus comprises a sensor part 10 and a measurement processing part 20. The sensor part 10 includes a first light source 11, a second light source 12, a light receivinq element 13 and a preamplifier 14. The first light source 11 generates optical pulses Il having a wavelength ~ having a large absorbance to a specific dye.
The second light source 12 generates optical pulses I2 - having a wavelength ~2 having no absorbance to the specific - 35 dye. The light receiving element 13 receives light applied to vital tissue 15 from the light sources 11 and 12 to pass through a prescribed optical path through the tissue 15.
,; ~
,, ' ' ' -: ' , :" ~ ' .. . .
'' ' -~ ~ :, :
:~ , ~ 1327401 . 11 The light sources 11 and 12 are driven by the measurement processing part 20 to alternately emit light by pulse operation, respectively.
The measurement processing part 20 includes a CPU
34 which serves as arithmetic means. The CPU 34 supplies a start signal to an oscillation circuit 24 and to a timing ~ circuit 23 through an I/0 port 32. The oscillation circuit - 24 produces 2 prescribed clock signal. This clock signal and the aforementioned start signal are utilized to supply a constant current i~ to the first light source 11 and a constant current i2to the second light source 12, from a constant current circuit 21 through the timing circuit 23 and a decoder 22 at timing TMI and TM~ as shown in Figure ~ 6.
`, 15The light Il emitted from the first light source ~1 and the light I2 emitted from the second light source 12 pass through the prescribed optical path in the vital ;~ tissue 15, to be incident upon the light receiving element 13. A current generated from the light receiving element ` 20 13 is supplied to the preamplifier 14 performing a current-to-voltage conversion and amplifying the signal to be supplied to the measurement processing part 20. Output of the preamplifier 14 is amplified to a level within a prescribed range by an amplifier 16 provided in the measurement processing part 20, whereby an output such as VPD shown in Figure 6 is obtained. A sample and hold circuit 28 samples and holds the output from the amplifier 16 on the basis of a timing signal TM2, shown in Figure 6, generated by the timing circuit 23 and a decoder 25.
30The signal thus sampled and held is selected by a multiplexer 29 and converted into a digital signal by an A-D converter 30, to be data-latched by a data latch 31. At this time, the multiplexer 29, the A-D converter 30 and the data latch 31 are controlled in timing by the timing circuit 23 and the decoder 26.
The latched data are ti~ed by a decoder 27 through - a select signal outputted from the CPU 34 through the I/0 , . - , , . .
' ,, ,- , , ' ': .
~ 1327401 port 32, for storing in a RAM 35 as digital signals Ll and L2. The I/O port 32 is connected with a buzzer 33, which provides a reminder or timing signal for injecting the specific dye. Further, the CPU 34 is connected with the RAM 35, a ROM 36, a display part 37 and a sample and hold circuit 28. The RAM 35 is adapted to store data as shown in Figure 7 as hereinafter described, and the ROM 36 stores programs based on flow charts shown in Figures 8A to 8D as hereinafter described. The display part 37 displays data as shown in Figures 9 to 12, as hereinafter described. A
printer 38 is adapted to print the result of a liver function test.
A function section 39 includes an alarm LED 40, first and second calibration keys 41 and 44, a start key 42 and a print key 43. The alarm LED 40 is adapted to display an alarm when the reliability of the test result is small.
The first calibration key 41 is adapted to set a first - biocalibration mode before injection of a specific dye.
The second calibration key 44 is adapted to set a second biocalibration mode after injection of the specific dye.
The start key 42 provides a starting command signal to start a measurement mode. ~he print key 43 is adapted to ~provide a printout of the test result.
- In the aforementioned exemplary structure shown in Figure 5, the light emitted from the first and second light - sources 11 and 12 to pass through the prescribed optical ; path in the vital tissue lS, is received by a single light receiving element 13. However, the invention is not ~;~ restricted to this example. Rather, light receiving 30 elements may be provided in correspondence to the first and second light sources 11 and 12 respectively, to sample outputs of the respective light receiving elements, thereby to read the respective sampling outputs by the CPU 34 in a time-sharing manner. Alternately, a single light source 35 commonly emitting light having a wavelength ~l absorbed by specific dye and light having a wavelength ~2 not absorbed by the same, may be provided as light source means, with " ~
.. . .
- : .
-.
.
,`~ . .
,, .
1327~01 ~ 13 -~ provision of two filters for individually transmitting the light of the respective wavelengths and light receiving elements corresponding to the respective ones of the filters.
Figure 7 illustrates data stored in the RAM 35 as shown in Figure 5, and Figures 8A to 8D are flow charts for illustrating a concrete operation of the embodiment of the present invention, while Figures 9 to 12 are illustrative of exemplary displays on the display part 37 shown in Figure 5, Figure 13 is illustrative of an exemplary disappearance curve of a specific dye, and the blood plasma disappearance rate k and the "T-minute retention rate" R %
measured by the present apparatus.
With reference to Figures 5, 8A to 8D and 13, $he operation of the embodiment of the present invention will now be described.
~ The operation of the present apparatus includes a ; data sampling mode, first and second biocalibration modes, ; an initiating mode and a measurement mode. Figures 8A, 8B, 8C and 8D show the operation flows of these modes `~ respectively.
First, it is pointed out that the data sampling -~ mode shown in Figure 8A is executed as subroutines in the biocalibration modes and the measurement mode as ~; 25 hereinafter described. Steps (abbreviated as SP in the figures) SP11 to SP16 are adapted to quantities of light I"
I2 of a pair of wavelengths ~ and ~2 after passage through a measured object and store the same in the RAM 35.
Namely, the CPU 34 outputs the start signal from a line shown in Figure 5 through the I/0 port 32 at the step SP11.
The values Ll and L2 are data-latched by the start signal, as hereinabove described. The CPU 34 waits until the data - are latched at the step SP12.
; Then, at the step SP13, the CPU 34 outputs the selected signal to a selected line shown in Figure 5 through the I/0 port 32, to read the data of L~ through the ,. .~ , , , ~ .
`
: - . . , ' ' . . ` -.
I/O port 32 at the step SP14, thereby to store the same in a storage area 8al of the RAM 35 as shown in Figure 7.
Similarly, the CPU 34 stores the data of L2 in a storage area 8a2 of the RAM 35 at the steps SP15 and SP16.
upon completion of the aforementioned operation at the step SP16, the CPU 34 returns to the original step.
This will be described with reference to Figure 8B showing the biocalibration mode and Figure 8D showing the measurement mode.
Figure 8B shows the operation flow chart of the first biocalibration mode, which is started when power is supplied to the apparatus or upon completion of the operation of the measurement mode shown in Figure 8D, as hereinafter described. At a step SP21, the CPU 34 makes , the biocalibration mode appear on the display part 37.
This display shows that the apparatus enters the biocalibration mode and indicates that the sensor part 10 should now be attached to a tissue 15, as shown in Figure 9, for example.
In accordance with this indication, an operator attaches the sensor part 10 to the vital tissue 15.
~ Thereafter the CPU 34 waits until the calibration '~ key 41 is operated at a step SP22. When the calibration key 41 is operated, the CPU 34 advances to a step SP23, to execute the data sampling subroutine shown in Figure 8A, as i hereinabove described.
Then, the CPU 34 controls the constant current circuit 21 as shown in Figure 5 so that the data Ll and L2 - read at the step SP23, are within ranges of light quantity data L~ and LM~stored in storage areas 8bl and 8b2 of the RAM 35. The CPU 34 then stores current set values il and i2 in storage areas 8cl and 8c2 in the RAM 35. Thereafter the currents il and i2 regularly flow to the light sources 11 ;~ and 12. Initializing operation for the aforementioned currents will be described in further detail with reference to Figure 8C.
. .
:
~, ,~
~, , ,- .. . .
, ' ' , .
.,,; , . . .
,"
Then, the cPu 34 sounds the buzzer at a step SP25, to inform that initialization is completed. Subsequent steps SP26 to SP29 are shown in the flow chart for ~- performing the aforementioned biocalibration. In more concrete terms, the CPU 34 samples the values of Ll and : a times respectively, at the steps SP26 and SP27, to cause CLI(l) to CLI(n) to be stored in storage areas 8dl to 8dn and C~(1) to C~(n) to be stored in storage areas 8el to 8en. At the subsequent step SP28, the CPU 34 performs a regression line analysis with respect to logCL~(I) and logC~(I) (I = 1 to n), in accordance with the following ` operation expression:
;~ logC~I~I) = A1 logC~ B
.'' 15 The CPU 34 finds the values A1 and Bl in the above operation expression, a correlation coefficient rl and the maximum value of CLI(I) (I = 1 to n) as CLlo, to store the same in storage areas 8fl, 8f2, 8f3 and 8f4 in the RAM 35 respectively.
Then, at the step SP29, the CPU 34 determines whether or not the correlation coefficient rl is at least 0.998 in order to verify the reliability of the biocalibration, advances to a step SP30 if the same is less than 0.998 to light the alarm LED 40, and returns to the step SP22 to again perform a biocalibration. On the other hand, if a determination is made that the correlation coefficient r~ is at least 0.998, the CPU 34 advances to the measurement mode as shown in Figure 8D. The reference value 0.998 of the correlation coefficient rl herein employed, is a mere example, which is determined by performance of the entire apparatus. During the data sampling that takes place n times at the step SP26, the testee raises and brings down his hand and presses the same by the sensor, in order to change the blood volume in the organism.
,,~
!
` ' '.
' ' ., ~ ~ ~ ' '' .
'; ' ' ~` --` 1327401 With reference to Figure 8C, the aforementioned initializing operation at the step SP24 as shown in Figure 8B will now be described in more detail.
The light quantity data L~ and L2 f the light of the wavelengths ~ and ~2 are stored in the storage areas 8al and 8a2 of the RAM 35. At a step SP241, the CPU 34 stores the values of Lland L2 in storage areas 8hl and 8h2 in the RAM 35 as L0~ and LO~2, respectively. Then the cPu 34 executes steps SP242 to SP249, to adjust the set values of the currents flowing from the constant current circuit 21, so that L0~ and L0~2 are set between the light quantity data L~ and LM~ (L~>LM~) stored in the storage areas 8bl ; and 8b2 of the RAM 35.
; More specifically, if L0~ is greater than L~ at the step SP242, the CPU 34 advances to the step SP243 to set the current set value i~at a small value to again execute the steps SP23 and SP241, and a determination is again made as to whether or not L0~ is greater than L~ at the step SP242. If LO~I is less than L~, the CPU 34 advances to the step SP244 to determine whether or not L0 is less than LM~. If L0~ is less than LM~ the CPU 34 increases the value of the current set value i~ at the step ~SP245, to return to the aforementioned step SP23. This -;operation is repeated to fix the current set value i~ so ~ 25 that L0~ is between L~ and LM~.
--~Then, at the steps SP246 to SP249, the current set value i2 is fixed so that LO~2 is between L~ and LMN, similarly to the steps SP242 to SP245. Thus, the current set values il and i2 finally fixed in the steps SP23 to SP249 are stored in the storage areas 8cl and 8c2 of the RAM 35.
The measurement mode will now be described with -reference to Figure 8D. At a step SP41, the CPU 34 displays on display part 37 an instruction to prepare the injection of the specific dye, as shown in Figure 10. In accordance with the display, the operator prepares for the injection of the specific dye into the testee. At a step '. :
, ,,; ., ,. . .
.":
;, . - : -:, . .
.~ , .
. X
. ~
, ~,, .
i, .
17 1~27401 SP42, the CPU 34 waits until the start key 42 is ~perated.
Upon a determination that the start key 42 has been operated, the CPU 34 displays a timing signal for injecting ~ the specific dye at a step SP43, while sounding the buzzer ; 5 33. This is displayed as 1 ~ 2 ~ 3 ~ 4 ~ 5 as shown in Figure 11, for example, so that the measurer injects the ` specific dye upon display of "5". The CPU 34 generates a ;i first sound by the buzzer 33 with the displays of ~'1", "2", "3" and "4", while generating a different sound by the -~ 10 buzzer 33 upon display of "5".
Upon generation of the sound and the display, the measurer injects the specific dye. The CPU 34 sets "0" as the initial value of a timer at a step SP44. Then, at a - step SP45, the CPU 34 executes a data sampling program, which is the subroutine as hereinabove described with ` reference to Figure 8A. Then, the sampling data are stored - in the storage areas 8all to 8aln and 8a21 to 8a2n of the RAM 35 as Ll(1) to Ll(n) and ~(1) to L2(n), respectively.
One sampling time ITM is expressed as:
ITN = TS/(~-1) wherein m represents the sampling number of the disappearance curve of the specific dye, I represents an integer between 1 to m and TS represents a measuring time of the disappearance curve. This coincides with the injection time of the specific dye if I = 1, as a matter of course. The CPU 34 determines whether or not i is greater than m at a step SP46 and returns to the step SP45 if i is less than m, to repeat the sampling and storing. Upon a determination that i is greater than m, the CPU 34 advances to a step SP47 and performs a second biocalibration similarly to the above description with reference to Figure 8B, to obtain constants A2 and B2 and a correlation function r2 and store the same in the storage areas 8f5, 8f6 and 8f7 of the RAM 35 respectively. The second biocalibration is not restricted to the step SP47, but may be performed at . .
~'-J.
' ' . - :
~; ;
, ' ' .: ' .
'.:, ,, ~; 18 ~; the steps SP45 and SP46 in a uniformly distributed state of the ICG concentration in the blood after the injection of the ICG. This second calibration may be initiated through the calibration key 44 shown in Figure 5.
5At a step SP48, the CPU 34 performs an operation based on the following operation expression by using the -- constants A1, B1, A2 and s2 obtained in the first and second biocalibration modes as hereinabove described and stored in ~ the storage areas 8fl, 8f2, 8f5 and sf6 of the RAM 35 to ;~ lo store Cg(I) in a storage area 8gl to 8gm of the Ram 35:
~` ~g~ I ) = logC~0llogL~0(I) - ~Al log~(I) I Bl) ~, 210gCI-10 -- ~A~ logL2( :- lS
~- logL10 = tA1 - B2 -- A2- B1) / ~A1 -- A2) .
The value of Cg(I) is displayed on the display ' part 37 at the step SP48 in a mode shown in Figure 12, for example. Referring to Figure 12, the abscissa indicates -~- the elapsed time from the injection of the specific dye and " the ordinate indicates the value of Cg(I). The data Cg(I) l;
stored in the storage areas 8gl to 8gm of the RAM 35 draw a disappearance curve of the specific dye as shown in Figure 13, for example, and the leading edge thereof is detected, so that data preceding the same are subtracted as baselines from the respective values of Cg(I) at a step ~ SP49, to be again stored in the storage areas 8gl to 8gm.
- - The data sampling times T~ to T2 at the step SP45 may be average values of k times, in order to improve the accuracy of the measurement.
~- Then, at a step SP51, the CPU 34 finds the constants A and B by using the method of least squares in a simulation curve of:
Cg(I) = AeB~
; I = Ts/(m - 1) (min.) :, .
. ~., ,~.
~,,,, ' .
,i.,, .-................................. ,. .. :, . ,:, .
.,.,, ~
, ` 13274~
,~. 19 with respect to data between times Tl to T2 (0~T~<T2<Ts) within the data Cg(I) stored in the storage areas 8gl to 8gm.
Then, the CPU 34 performs an operation of the blood plasma disappearance rate k = ~ and the "T-minute retention rate" R % = e~~T at a step SP52, to evaluate k and R %. The values k and R % thus evaluated are stored in storage areas 8jl and 8j2 of the RAM 35, respectively. At this time, the CPU 34 processes a correlation coefficient r2 by the method of least squares and stores the resulting correlation coefficient r2 in a storage area 8j3 of the R~M
35. The CPU 34 further generates an end sound through the , buzzer 33.
Further, the CPU 34 displays the values k and R %
on the display part 37 in a mode shown in Figure 12, for ` example. Then, at a step SP53, the CPU 34 determines whether or not the correlation coefficient r2is less than 0.95, for example. This determination is made to check the degree of correlation, since the correlation is improved as the correlation coefficient r~ approaches -1. The value 0.95 is provisionally selected between zero and -1, and the reliability of the apparatus is improved as the value - comes closer to -1.
If the correlation coeffici~ent r2 is greater than - 25 0.95, for example, the CPU determines that reliability is insufficient and lights up the alarm LED 40 at the step SP54. On the other hand, if the correlation coefficient r2 .
is less than -0.95, for example, at the step SP53, the CPU
- 34 advances to a step SP55 without flashing the alarm LED
44, since the measurement is reliable. At the step SP55, ~ the CPU 34 determines whether or not the print key 43 is :~- operated, to cause the printer 38 to print the values k and R % if the determination is: YES.
If necessary, the CPU 34 causes the printing of the characteristic dye disappearance curves of Cg(I) stored in the storage areas 8gl to 8gn of the RAM 35 and advances to the first biocalibration mode shown in Figure 8B. Also `',,' : ::
, . . .
"
. ~ - . .
., . ~. .
when a determination is made that the print key 43 is not operated at the step SP55, the cPu 34 advances to the first biocalibration mode.
Figure 14B illustrates two experimental calibration curves whereby curve a represents the experiment before the dye injection and curve b is a calibration curve representing the experiment after a prescribed period of time has passed following the injection.
In the experiment shown in Figure 14A, the sensor part 10 was attached to a left fingertip of a male patient (age: 66, weight: 48Kq) having a hepatic disease. An aqueous solution containing 24 mg of ICG (0.5 mg per Kg) was intravenously injected into the vein of his right lower arm. Figure 15 shows the time change of L~ and ~ while employing a light emitting diode having a wavelength ~ =
810 nm as the first light source 11, and a light emitting diode of wavelength ~2 = 940 nm as the second light source 12.
' 20 The value k calculated by the ICG disappearance curve was 0.09 as shown in Figure 14A and the value R % was 24.1%, which is substantially in agreement with the measurements obtained by the conventional blood collection method where k = 0.099 and the value R % was 22.6%. Figure - 25 15 also shows raw data of L~ and L2. It is clearly . understood from Figure 14B that the blood volume in the organism fluctuated.
, The value k obtained through the present invention ~` can be extended to an apparatus for obtaining and ,; 30 calculating values k for various ICG doses.
According to the present invention the above-described biocalibrations are performed to obtain the blood plasma disappearance rate of the specific dye and the retention rate on the basis of a plurality of sampling outputs during a prescribed period after injection of the -` specific dye and to obtain the required coefficients of the - regression line expressions and prescribed operation :.
., ,~.
~ . , , , , `1327401 . expressions. Thus, a correct time management of the disappearance curve of the specific dye is made possible to obtain correct data. Further, the blood plasma disappearance rate and the retention rate can be obtained not merely from several samples as is the case in the conventional blood collection method, but from a large number of disappearance curve data whereby the reliability of the data is improved.
Although the present invention has been described : 10 and illustrated in detail, it is clearly understood that the same is by way of illustration and example only and is not to be taken by way of limitation, the spirit and scope of the present invention being limited only by the terms of the appended claims.
-`;
~ , :~.,'.
::;
'.;'' ,': .
;, ' . .
. ~, "j , ~;
~ "
. 1 , , , -.,~, .
,. : , , ', ' ,, '
., ~; ~12) Cg = Ae-B~
:~ .
... .
. ,. . ~
1~27401 . 10 wherein t represents the elapsed time after injection of the specific dye and symbols A and B represent constants.
-` The constants A and B are found by the above expression (12). The blood plasma disappearance rate k and the retention rate R % are expressed as follows:
~13) k = B
(14) R % = e -BT
:, wherein T represents the elapsed time in minutes after injection of the dye. These two rates characteristically express the intake of the specific dye into the liver.
Since the retention rate applies to an elapsed time of T
~` minutes, this retention rate may be referred to as the "T-: 15 minute retention rate".
While the biocalibration employed in the present ` invention has been described above, an embodiment of the ~ present invention employing the aforementioned ; biocalibration will now be described.
Figure 5 is a schematic block diagram showing an ~ embodiment of the present invention, Figure 6 is a timing i chart for detecting quantities of light of wavelengths ~
and ~2 after passage through a prescribed optical path through a measured object, and Figure 7 illustrates data stored in a RAM as shown in Figure 5.
Referring to Figure 5, the present liver function testing apparatus comprises a sensor part 10 and a measurement processing part 20. The sensor part 10 includes a first light source 11, a second light source 12, a light receivinq element 13 and a preamplifier 14. The first light source 11 generates optical pulses Il having a wavelength ~ having a large absorbance to a specific dye.
The second light source 12 generates optical pulses I2 - having a wavelength ~2 having no absorbance to the specific - 35 dye. The light receiving element 13 receives light applied to vital tissue 15 from the light sources 11 and 12 to pass through a prescribed optical path through the tissue 15.
,; ~
,, ' ' ' -: ' , :" ~ ' .. . .
'' ' -~ ~ :, :
:~ , ~ 1327401 . 11 The light sources 11 and 12 are driven by the measurement processing part 20 to alternately emit light by pulse operation, respectively.
The measurement processing part 20 includes a CPU
34 which serves as arithmetic means. The CPU 34 supplies a start signal to an oscillation circuit 24 and to a timing ~ circuit 23 through an I/0 port 32. The oscillation circuit - 24 produces 2 prescribed clock signal. This clock signal and the aforementioned start signal are utilized to supply a constant current i~ to the first light source 11 and a constant current i2to the second light source 12, from a constant current circuit 21 through the timing circuit 23 and a decoder 22 at timing TMI and TM~ as shown in Figure ~ 6.
`, 15The light Il emitted from the first light source ~1 and the light I2 emitted from the second light source 12 pass through the prescribed optical path in the vital ;~ tissue 15, to be incident upon the light receiving element 13. A current generated from the light receiving element ` 20 13 is supplied to the preamplifier 14 performing a current-to-voltage conversion and amplifying the signal to be supplied to the measurement processing part 20. Output of the preamplifier 14 is amplified to a level within a prescribed range by an amplifier 16 provided in the measurement processing part 20, whereby an output such as VPD shown in Figure 6 is obtained. A sample and hold circuit 28 samples and holds the output from the amplifier 16 on the basis of a timing signal TM2, shown in Figure 6, generated by the timing circuit 23 and a decoder 25.
30The signal thus sampled and held is selected by a multiplexer 29 and converted into a digital signal by an A-D converter 30, to be data-latched by a data latch 31. At this time, the multiplexer 29, the A-D converter 30 and the data latch 31 are controlled in timing by the timing circuit 23 and the decoder 26.
The latched data are ti~ed by a decoder 27 through - a select signal outputted from the CPU 34 through the I/0 , . - , , . .
' ,, ,- , , ' ': .
~ 1327401 port 32, for storing in a RAM 35 as digital signals Ll and L2. The I/O port 32 is connected with a buzzer 33, which provides a reminder or timing signal for injecting the specific dye. Further, the CPU 34 is connected with the RAM 35, a ROM 36, a display part 37 and a sample and hold circuit 28. The RAM 35 is adapted to store data as shown in Figure 7 as hereinafter described, and the ROM 36 stores programs based on flow charts shown in Figures 8A to 8D as hereinafter described. The display part 37 displays data as shown in Figures 9 to 12, as hereinafter described. A
printer 38 is adapted to print the result of a liver function test.
A function section 39 includes an alarm LED 40, first and second calibration keys 41 and 44, a start key 42 and a print key 43. The alarm LED 40 is adapted to display an alarm when the reliability of the test result is small.
The first calibration key 41 is adapted to set a first - biocalibration mode before injection of a specific dye.
The second calibration key 44 is adapted to set a second biocalibration mode after injection of the specific dye.
The start key 42 provides a starting command signal to start a measurement mode. ~he print key 43 is adapted to ~provide a printout of the test result.
- In the aforementioned exemplary structure shown in Figure 5, the light emitted from the first and second light - sources 11 and 12 to pass through the prescribed optical ; path in the vital tissue lS, is received by a single light receiving element 13. However, the invention is not ~;~ restricted to this example. Rather, light receiving 30 elements may be provided in correspondence to the first and second light sources 11 and 12 respectively, to sample outputs of the respective light receiving elements, thereby to read the respective sampling outputs by the CPU 34 in a time-sharing manner. Alternately, a single light source 35 commonly emitting light having a wavelength ~l absorbed by specific dye and light having a wavelength ~2 not absorbed by the same, may be provided as light source means, with " ~
.. . .
- : .
-.
.
,`~ . .
,, .
1327~01 ~ 13 -~ provision of two filters for individually transmitting the light of the respective wavelengths and light receiving elements corresponding to the respective ones of the filters.
Figure 7 illustrates data stored in the RAM 35 as shown in Figure 5, and Figures 8A to 8D are flow charts for illustrating a concrete operation of the embodiment of the present invention, while Figures 9 to 12 are illustrative of exemplary displays on the display part 37 shown in Figure 5, Figure 13 is illustrative of an exemplary disappearance curve of a specific dye, and the blood plasma disappearance rate k and the "T-minute retention rate" R %
measured by the present apparatus.
With reference to Figures 5, 8A to 8D and 13, $he operation of the embodiment of the present invention will now be described.
~ The operation of the present apparatus includes a ; data sampling mode, first and second biocalibration modes, ; an initiating mode and a measurement mode. Figures 8A, 8B, 8C and 8D show the operation flows of these modes `~ respectively.
First, it is pointed out that the data sampling -~ mode shown in Figure 8A is executed as subroutines in the biocalibration modes and the measurement mode as ~; 25 hereinafter described. Steps (abbreviated as SP in the figures) SP11 to SP16 are adapted to quantities of light I"
I2 of a pair of wavelengths ~ and ~2 after passage through a measured object and store the same in the RAM 35.
Namely, the CPU 34 outputs the start signal from a line shown in Figure 5 through the I/0 port 32 at the step SP11.
The values Ll and L2 are data-latched by the start signal, as hereinabove described. The CPU 34 waits until the data - are latched at the step SP12.
; Then, at the step SP13, the CPU 34 outputs the selected signal to a selected line shown in Figure 5 through the I/0 port 32, to read the data of L~ through the ,. .~ , , , ~ .
`
: - . . , ' ' . . ` -.
I/O port 32 at the step SP14, thereby to store the same in a storage area 8al of the RAM 35 as shown in Figure 7.
Similarly, the CPU 34 stores the data of L2 in a storage area 8a2 of the RAM 35 at the steps SP15 and SP16.
upon completion of the aforementioned operation at the step SP16, the CPU 34 returns to the original step.
This will be described with reference to Figure 8B showing the biocalibration mode and Figure 8D showing the measurement mode.
Figure 8B shows the operation flow chart of the first biocalibration mode, which is started when power is supplied to the apparatus or upon completion of the operation of the measurement mode shown in Figure 8D, as hereinafter described. At a step SP21, the CPU 34 makes , the biocalibration mode appear on the display part 37.
This display shows that the apparatus enters the biocalibration mode and indicates that the sensor part 10 should now be attached to a tissue 15, as shown in Figure 9, for example.
In accordance with this indication, an operator attaches the sensor part 10 to the vital tissue 15.
~ Thereafter the CPU 34 waits until the calibration '~ key 41 is operated at a step SP22. When the calibration key 41 is operated, the CPU 34 advances to a step SP23, to execute the data sampling subroutine shown in Figure 8A, as i hereinabove described.
Then, the CPU 34 controls the constant current circuit 21 as shown in Figure 5 so that the data Ll and L2 - read at the step SP23, are within ranges of light quantity data L~ and LM~stored in storage areas 8bl and 8b2 of the RAM 35. The CPU 34 then stores current set values il and i2 in storage areas 8cl and 8c2 in the RAM 35. Thereafter the currents il and i2 regularly flow to the light sources 11 ;~ and 12. Initializing operation for the aforementioned currents will be described in further detail with reference to Figure 8C.
. .
:
~, ,~
~, , ,- .. . .
, ' ' , .
.,,; , . . .
,"
Then, the cPu 34 sounds the buzzer at a step SP25, to inform that initialization is completed. Subsequent steps SP26 to SP29 are shown in the flow chart for ~- performing the aforementioned biocalibration. In more concrete terms, the CPU 34 samples the values of Ll and : a times respectively, at the steps SP26 and SP27, to cause CLI(l) to CLI(n) to be stored in storage areas 8dl to 8dn and C~(1) to C~(n) to be stored in storage areas 8el to 8en. At the subsequent step SP28, the CPU 34 performs a regression line analysis with respect to logCL~(I) and logC~(I) (I = 1 to n), in accordance with the following ` operation expression:
;~ logC~I~I) = A1 logC~ B
.'' 15 The CPU 34 finds the values A1 and Bl in the above operation expression, a correlation coefficient rl and the maximum value of CLI(I) (I = 1 to n) as CLlo, to store the same in storage areas 8fl, 8f2, 8f3 and 8f4 in the RAM 35 respectively.
Then, at the step SP29, the CPU 34 determines whether or not the correlation coefficient rl is at least 0.998 in order to verify the reliability of the biocalibration, advances to a step SP30 if the same is less than 0.998 to light the alarm LED 40, and returns to the step SP22 to again perform a biocalibration. On the other hand, if a determination is made that the correlation coefficient r~ is at least 0.998, the CPU 34 advances to the measurement mode as shown in Figure 8D. The reference value 0.998 of the correlation coefficient rl herein employed, is a mere example, which is determined by performance of the entire apparatus. During the data sampling that takes place n times at the step SP26, the testee raises and brings down his hand and presses the same by the sensor, in order to change the blood volume in the organism.
,,~
!
` ' '.
' ' ., ~ ~ ~ ' '' .
'; ' ' ~` --` 1327401 With reference to Figure 8C, the aforementioned initializing operation at the step SP24 as shown in Figure 8B will now be described in more detail.
The light quantity data L~ and L2 f the light of the wavelengths ~ and ~2 are stored in the storage areas 8al and 8a2 of the RAM 35. At a step SP241, the CPU 34 stores the values of Lland L2 in storage areas 8hl and 8h2 in the RAM 35 as L0~ and LO~2, respectively. Then the cPu 34 executes steps SP242 to SP249, to adjust the set values of the currents flowing from the constant current circuit 21, so that L0~ and L0~2 are set between the light quantity data L~ and LM~ (L~>LM~) stored in the storage areas 8bl ; and 8b2 of the RAM 35.
; More specifically, if L0~ is greater than L~ at the step SP242, the CPU 34 advances to the step SP243 to set the current set value i~at a small value to again execute the steps SP23 and SP241, and a determination is again made as to whether or not L0~ is greater than L~ at the step SP242. If LO~I is less than L~, the CPU 34 advances to the step SP244 to determine whether or not L0 is less than LM~. If L0~ is less than LM~ the CPU 34 increases the value of the current set value i~ at the step ~SP245, to return to the aforementioned step SP23. This -;operation is repeated to fix the current set value i~ so ~ 25 that L0~ is between L~ and LM~.
--~Then, at the steps SP246 to SP249, the current set value i2 is fixed so that LO~2 is between L~ and LMN, similarly to the steps SP242 to SP245. Thus, the current set values il and i2 finally fixed in the steps SP23 to SP249 are stored in the storage areas 8cl and 8c2 of the RAM 35.
The measurement mode will now be described with -reference to Figure 8D. At a step SP41, the CPU 34 displays on display part 37 an instruction to prepare the injection of the specific dye, as shown in Figure 10. In accordance with the display, the operator prepares for the injection of the specific dye into the testee. At a step '. :
, ,,; ., ,. . .
.":
;, . - : -:, . .
.~ , .
. X
. ~
, ~,, .
i, .
17 1~27401 SP42, the CPU 34 waits until the start key 42 is ~perated.
Upon a determination that the start key 42 has been operated, the CPU 34 displays a timing signal for injecting ~ the specific dye at a step SP43, while sounding the buzzer ; 5 33. This is displayed as 1 ~ 2 ~ 3 ~ 4 ~ 5 as shown in Figure 11, for example, so that the measurer injects the ` specific dye upon display of "5". The CPU 34 generates a ;i first sound by the buzzer 33 with the displays of ~'1", "2", "3" and "4", while generating a different sound by the -~ 10 buzzer 33 upon display of "5".
Upon generation of the sound and the display, the measurer injects the specific dye. The CPU 34 sets "0" as the initial value of a timer at a step SP44. Then, at a - step SP45, the CPU 34 executes a data sampling program, which is the subroutine as hereinabove described with ` reference to Figure 8A. Then, the sampling data are stored - in the storage areas 8all to 8aln and 8a21 to 8a2n of the RAM 35 as Ll(1) to Ll(n) and ~(1) to L2(n), respectively.
One sampling time ITM is expressed as:
ITN = TS/(~-1) wherein m represents the sampling number of the disappearance curve of the specific dye, I represents an integer between 1 to m and TS represents a measuring time of the disappearance curve. This coincides with the injection time of the specific dye if I = 1, as a matter of course. The CPU 34 determines whether or not i is greater than m at a step SP46 and returns to the step SP45 if i is less than m, to repeat the sampling and storing. Upon a determination that i is greater than m, the CPU 34 advances to a step SP47 and performs a second biocalibration similarly to the above description with reference to Figure 8B, to obtain constants A2 and B2 and a correlation function r2 and store the same in the storage areas 8f5, 8f6 and 8f7 of the RAM 35 respectively. The second biocalibration is not restricted to the step SP47, but may be performed at . .
~'-J.
' ' . - :
~; ;
, ' ' .: ' .
'.:, ,, ~; 18 ~; the steps SP45 and SP46 in a uniformly distributed state of the ICG concentration in the blood after the injection of the ICG. This second calibration may be initiated through the calibration key 44 shown in Figure 5.
5At a step SP48, the CPU 34 performs an operation based on the following operation expression by using the -- constants A1, B1, A2 and s2 obtained in the first and second biocalibration modes as hereinabove described and stored in ~ the storage areas 8fl, 8f2, 8f5 and sf6 of the RAM 35 to ;~ lo store Cg(I) in a storage area 8gl to 8gm of the Ram 35:
~` ~g~ I ) = logC~0llogL~0(I) - ~Al log~(I) I Bl) ~, 210gCI-10 -- ~A~ logL2( :- lS
~- logL10 = tA1 - B2 -- A2- B1) / ~A1 -- A2) .
The value of Cg(I) is displayed on the display ' part 37 at the step SP48 in a mode shown in Figure 12, for example. Referring to Figure 12, the abscissa indicates -~- the elapsed time from the injection of the specific dye and " the ordinate indicates the value of Cg(I). The data Cg(I) l;
stored in the storage areas 8gl to 8gm of the RAM 35 draw a disappearance curve of the specific dye as shown in Figure 13, for example, and the leading edge thereof is detected, so that data preceding the same are subtracted as baselines from the respective values of Cg(I) at a step ~ SP49, to be again stored in the storage areas 8gl to 8gm.
- - The data sampling times T~ to T2 at the step SP45 may be average values of k times, in order to improve the accuracy of the measurement.
~- Then, at a step SP51, the CPU 34 finds the constants A and B by using the method of least squares in a simulation curve of:
Cg(I) = AeB~
; I = Ts/(m - 1) (min.) :, .
. ~., ,~.
~,,,, ' .
,i.,, .-................................. ,. .. :, . ,:, .
.,.,, ~
, ` 13274~
,~. 19 with respect to data between times Tl to T2 (0~T~<T2<Ts) within the data Cg(I) stored in the storage areas 8gl to 8gm.
Then, the CPU 34 performs an operation of the blood plasma disappearance rate k = ~ and the "T-minute retention rate" R % = e~~T at a step SP52, to evaluate k and R %. The values k and R % thus evaluated are stored in storage areas 8jl and 8j2 of the RAM 35, respectively. At this time, the CPU 34 processes a correlation coefficient r2 by the method of least squares and stores the resulting correlation coefficient r2 in a storage area 8j3 of the R~M
35. The CPU 34 further generates an end sound through the , buzzer 33.
Further, the CPU 34 displays the values k and R %
on the display part 37 in a mode shown in Figure 12, for ` example. Then, at a step SP53, the CPU 34 determines whether or not the correlation coefficient r2is less than 0.95, for example. This determination is made to check the degree of correlation, since the correlation is improved as the correlation coefficient r~ approaches -1. The value 0.95 is provisionally selected between zero and -1, and the reliability of the apparatus is improved as the value - comes closer to -1.
If the correlation coeffici~ent r2 is greater than - 25 0.95, for example, the CPU determines that reliability is insufficient and lights up the alarm LED 40 at the step SP54. On the other hand, if the correlation coefficient r2 .
is less than -0.95, for example, at the step SP53, the CPU
- 34 advances to a step SP55 without flashing the alarm LED
44, since the measurement is reliable. At the step SP55, ~ the CPU 34 determines whether or not the print key 43 is :~- operated, to cause the printer 38 to print the values k and R % if the determination is: YES.
If necessary, the CPU 34 causes the printing of the characteristic dye disappearance curves of Cg(I) stored in the storage areas 8gl to 8gn of the RAM 35 and advances to the first biocalibration mode shown in Figure 8B. Also `',,' : ::
, . . .
"
. ~ - . .
., . ~. .
when a determination is made that the print key 43 is not operated at the step SP55, the cPu 34 advances to the first biocalibration mode.
Figure 14B illustrates two experimental calibration curves whereby curve a represents the experiment before the dye injection and curve b is a calibration curve representing the experiment after a prescribed period of time has passed following the injection.
In the experiment shown in Figure 14A, the sensor part 10 was attached to a left fingertip of a male patient (age: 66, weight: 48Kq) having a hepatic disease. An aqueous solution containing 24 mg of ICG (0.5 mg per Kg) was intravenously injected into the vein of his right lower arm. Figure 15 shows the time change of L~ and ~ while employing a light emitting diode having a wavelength ~ =
810 nm as the first light source 11, and a light emitting diode of wavelength ~2 = 940 nm as the second light source 12.
' 20 The value k calculated by the ICG disappearance curve was 0.09 as shown in Figure 14A and the value R % was 24.1%, which is substantially in agreement with the measurements obtained by the conventional blood collection method where k = 0.099 and the value R % was 22.6%. Figure - 25 15 also shows raw data of L~ and L2. It is clearly . understood from Figure 14B that the blood volume in the organism fluctuated.
, The value k obtained through the present invention ~` can be extended to an apparatus for obtaining and ,; 30 calculating values k for various ICG doses.
According to the present invention the above-described biocalibrations are performed to obtain the blood plasma disappearance rate of the specific dye and the retention rate on the basis of a plurality of sampling outputs during a prescribed period after injection of the -` specific dye and to obtain the required coefficients of the - regression line expressions and prescribed operation :.
., ,~.
~ . , , , , `1327401 . expressions. Thus, a correct time management of the disappearance curve of the specific dye is made possible to obtain correct data. Further, the blood plasma disappearance rate and the retention rate can be obtained not merely from several samples as is the case in the conventional blood collection method, but from a large number of disappearance curve data whereby the reliability of the data is improved.
Although the present invention has been described : 10 and illustrated in detail, it is clearly understood that the same is by way of illustration and example only and is not to be taken by way of limitation, the spirit and scope of the present invention being limited only by the terms of the appended claims.
-`;
~ , :~.,'.
::;
'.;'' ,': .
;, ' . .
. ~, "j , ~;
~ "
. 1 , , , -.,~, .
,. : , , ', ' ,, '
Claims (14)
1. A liver function testing apparatus for testing liver function, comprising:
light source means for exposing vital tissue to a first light signal capable of being absorbed by a specific dye injected into blood of said vital tissue, said dye to be taken in and removed by the liver, and to a second light signal capable of being absorbed by said specific dye;
photoelectric conversion means for outputting first and second photoelectric conversion signals obtained from said vital tissue and corresponding to said first light signal and to said second light signal applied to said vital tissue by said light source means;
sampling means for sampling said first and second photoelectric conversion signals a plurality of times;
first decision means for determining a first coefficient of a first regression line expression between said first and second photoelectric conversion signals on the basis of variable components in said blood included in said first and second photoelectric conversion signals sampled by said sampling means a plurality of times before injection of said specific dye;
second decision means for determining a second coefficient of a second regression line expression between said first and second photoelectric conversion signals on the basis of variable components in said blood included in said first and second photoelectric conversion signals sampled by said sampling means a plurality of times after a lapse of a prescribed period; and arithmetic means for storing a plurality of sampling signal outputs of said sampling means during a prescribed period of time following said injection of said specific dye for processing a value correlated with a specific dye concentration in said blood on the basis of said first and second coefficients of said first and second regression line expressions determined by said first and second decision means for obtaining a coefficient of a simulation function as a function of time by using the method of least squares on the basis of said processed value correlated with said specific dye concentration, for obtaining a blood plasma disappearance rate of said specific dye and a retention rate of said specific dye in said prescribed period of time on the basis of said simulation function coefficient.
light source means for exposing vital tissue to a first light signal capable of being absorbed by a specific dye injected into blood of said vital tissue, said dye to be taken in and removed by the liver, and to a second light signal capable of being absorbed by said specific dye;
photoelectric conversion means for outputting first and second photoelectric conversion signals obtained from said vital tissue and corresponding to said first light signal and to said second light signal applied to said vital tissue by said light source means;
sampling means for sampling said first and second photoelectric conversion signals a plurality of times;
first decision means for determining a first coefficient of a first regression line expression between said first and second photoelectric conversion signals on the basis of variable components in said blood included in said first and second photoelectric conversion signals sampled by said sampling means a plurality of times before injection of said specific dye;
second decision means for determining a second coefficient of a second regression line expression between said first and second photoelectric conversion signals on the basis of variable components in said blood included in said first and second photoelectric conversion signals sampled by said sampling means a plurality of times after a lapse of a prescribed period; and arithmetic means for storing a plurality of sampling signal outputs of said sampling means during a prescribed period of time following said injection of said specific dye for processing a value correlated with a specific dye concentration in said blood on the basis of said first and second coefficients of said first and second regression line expressions determined by said first and second decision means for obtaining a coefficient of a simulation function as a function of time by using the method of least squares on the basis of said processed value correlated with said specific dye concentration, for obtaining a blood plasma disappearance rate of said specific dye and a retention rate of said specific dye in said prescribed period of time on the basis of said simulation function coefficient.
2. A liver function testing apparatus according to claim 1, wherein said second decision means determines said second coefficient within a prescribed period of time following an injection of said specific dye in an arbitrary short period after a time when said specific dye is uniformly distributed in said blood.
3. A liver function testing apparatus according to claim 1, wherein said arithmetic means includes means for obtaining first dimensionless constants A1 and B1 by performing a regression line analysis in accordance with the following operation expression:
logCL1 = A1?logCL2 + B1 wherein CL1 and CL2 represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times before injection of said specific dye, and obtaining second dimensionless constants A2 and B2 by performing a regression line analysis in accordance with the following operation expression:
logCL1, = A2?logCL2, + B2 wherein CL1, and CL2, represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times after a lapse of a prescribed period of time following an injection of said specific dye, for obtaining:
LogL10 = (A1?B2 - A2?B1)/A1 - A2) as a blood-free point signifying that said tissue is substantially free of blood.
logCL1 = A1?logCL2 + B1 wherein CL1 and CL2 represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times before injection of said specific dye, and obtaining second dimensionless constants A2 and B2 by performing a regression line analysis in accordance with the following operation expression:
logCL1, = A2?logCL2, + B2 wherein CL1, and CL2, represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times after a lapse of a prescribed period of time following an injection of said specific dye, for obtaining:
LogL10 = (A1?B2 - A2?B1)/A1 - A2) as a blood-free point signifying that said tissue is substantially free of blood.
4. A liver function testing apparatus according to claim 3, wherein said arithmetic means includes means for processing a value Cg correlated with said specific dye concentration on the basis of obtained said constants Al and Bland said blood-free point L10 in accordance with the following operation expression:
5. A liver function testing apparatus according to claim 4, wherein said arithmetic means includes means for processing first constants A1 and B1 by performing a regression line analysis in accordance with the following operation expression:
logCL1 = A1?logCL2 + B1 wherein CL1 and CL2 represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times before injection of said specific dye, for obtaining second constants A2 and B2 by performing a regression line analysis in accordance with the following operation expression:
logCL1, = A2?logCL2, + B2 wherein CL1, and CL2, represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times within a prescribed period of time after injection of said specific dye in an arbitrary period after a time when said specific dye is uniformly distributed in said blood, for obtaining:
logL10 = (A1?B2 - A2?B1)/(A1 - A2) as a blood-free point signifying that said tissue is substantially free of blood.
logCL1 = A1?logCL2 + B1 wherein CL1 and CL2 represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times before injection of said specific dye, for obtaining second constants A2 and B2 by performing a regression line analysis in accordance with the following operation expression:
logCL1, = A2?logCL2, + B2 wherein CL1, and CL2, represent average voltage values of said first and second photoelectric conversion signals sampled by said sampling means a plurality of times within a prescribed period of time after injection of said specific dye in an arbitrary period after a time when said specific dye is uniformly distributed in said blood, for obtaining:
logL10 = (A1?B2 - A2?B1)/(A1 - A2) as a blood-free point signifying that said tissue is substantially free of blood.
6. A liver function testing apparatus according to claim 4, wherein said arithmetic means includes means for processing constants A and B on the basis of the following operation expression:
cg = Ae-Bt wherein t represents said prescribed period of time after injection of said specific dye.
cg = Ae-Bt wherein t represents said prescribed period of time after injection of said specific dye.
7. A liver function testing apparatus according to claim 1, wherein said arithmetic means includes means for solving the following operation expression:
k = B
wherein k represents said blood plasma disappearance rate.
k = B
wherein k represents said blood plasma disappearance rate.
8. A liver function testing apparatus according to claim 1 or 7, wherein said arithmetic means includes means for solving the following operation expression:
R % = e-BT
wherein R % represents said retention rate.
R % = e-BT
wherein R % represents said retention rate.
9. A liver function testing apparatus according to claim 1, wherein said decision means includes means for processing a correlation coefficient of said regression line expression, said liver function testing apparatus further including informing means for giving an alarm when said correlation coefficient processed by said means for processing said correlation coefficient is greater than a predetermined value.
10. A liver function testing apparatus according to claim 1, wherein said arithmetic means includes means for processing a correlation coefficient of said simulation function, said liver function testing apparatus further including informing means for giving an alarm when said correlation coefficient of said simulation function is greater than a predetermined value.
11. A liver function testing apparatus according to claim 1, 2, 3, 4, 5, 6, 7, 9 or 10, further including mode selection means for selecting a biocalibration mode for performing an operation for determining said coefficient of said regression line expression by said decision means, and a measurement mode for performing an operation for processing said value correlated with said specific dye concentration by said arithmetic means.
12. A liver function testing apparatus according to claim 11, further including arithmetic means for activating said decision means in response to selection of said biocalibration mode by said mode selection means.
13. A liver function testing apparatus according to claim 12, wherein said arithmetic means includes means for activating said arithmetic means in response to a selection of a measurement mode by said mode selection means.
14. A liver function testing apparatus according to claim 1, 2, 3, 4, 5, 6, 7, 9, 10, 12 or 13, further including set means for setting intensity levels of said first light signal and said second light signal emitted from said light source means so that levels of said first and second photoelectric conversion signals are within a predetermined range.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP287678/1987 | 1987-11-13 | ||
| JP62287678A JPH01129838A (en) | 1987-11-13 | 1987-11-13 | Liver function examination apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1327401C true CA1327401C (en) | 1994-03-01 |
Family
ID=17720304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000582563A Expired - Fee Related CA1327401C (en) | 1987-11-13 | 1988-11-08 | Liver function testing apparatus |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5054916A (en) |
| EP (1) | EP0316745B1 (en) |
| JP (1) | JPH01129838A (en) |
| KR (1) | KR910002652B1 (en) |
| CN (1) | CN1015826B (en) |
| CA (1) | CA1327401C (en) |
| DE (1) | DE3887638T2 (en) |
| RU (1) | RU2093064C1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02309929A (en) * | 1989-05-24 | 1990-12-25 | Sumitomo Electric Ind Ltd | Hepatic function inspecting apparatus |
| US5190038A (en) * | 1989-11-01 | 1993-03-02 | Novametrix Medical Systems, Inc. | Pulse oximeter with improved accuracy and response time |
| EP0505918B1 (en) * | 1991-03-25 | 1996-12-04 | Hoeft, Andreas, Prof. Dr. med. | Apparatus and method for determining heart minute volumes |
| JP3116252B2 (en) * | 1992-07-09 | 2000-12-11 | 日本光電工業株式会社 | Pulse oximeter |
| US5865738A (en) * | 1993-12-10 | 1999-02-02 | Regents Of The University Of California | Tissue viability monitor |
| US5497770A (en) * | 1994-01-14 | 1996-03-12 | The Regents Of The University Of California | Tissue viability monitor |
| US6280703B1 (en) | 1997-03-13 | 2001-08-28 | Mallinckrodt Inc. | Simultaneous multimodal measurement of physiological function |
| US5928625A (en) * | 1997-03-13 | 1999-07-27 | Mallinckrodt Inc. | Method of measuring physiological function |
| US6228344B1 (en) | 1997-03-13 | 2001-05-08 | Mallinckrodt Inc. | Method of measuring physiological function |
| CN102551670A (en) * | 2011-12-23 | 2012-07-11 | 北京华亘安邦科技有限公司 | Liver reserving function analyzer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1095114A (en) * | 1963-12-09 | 1967-12-13 | Atlas Werke Ag | Apparatus for the measurement of dye dilution in blood |
| US4017192A (en) * | 1975-02-06 | 1977-04-12 | Neotec Corporation | Optical analysis of biomedical specimens |
| US4100416A (en) * | 1977-03-02 | 1978-07-11 | Block Engineering, Inc. | Serum fluorescence suppression |
| JPS5524004A (en) * | 1978-06-22 | 1980-02-20 | Minolta Camera Kk | Oxymeter |
| US4569589A (en) * | 1983-05-25 | 1986-02-11 | University Of Pennsylvania | Lung water computer system |
| US4602641A (en) * | 1983-08-15 | 1986-07-29 | The Regents Of The University Of California | Method and apparatus for NMR detection and imaging of flowing fluid nuclei |
| IL84356A (en) * | 1986-11-05 | 1991-08-16 | Sumitomo Electric Industries | Liver function testing apparatus |
| JPS63165757A (en) * | 1986-12-26 | 1988-07-09 | Nippon Koden Corp | Apparatus for measuring change in concentration of pigment in blood |
-
1987
- 1987-11-13 JP JP62287678A patent/JPH01129838A/en active Granted
-
1988
- 1988-11-08 CA CA000582563A patent/CA1327401C/en not_active Expired - Fee Related
- 1988-11-08 US US07/268,735 patent/US5054916A/en not_active Expired - Fee Related
- 1988-11-09 DE DE88118658T patent/DE3887638T2/en not_active Expired - Fee Related
- 1988-11-09 EP EP88118658A patent/EP0316745B1/en not_active Expired - Lifetime
- 1988-11-10 KR KR1019880014750A patent/KR910002652B1/en not_active IP Right Cessation
- 1988-11-11 RU SU884356987A patent/RU2093064C1/en active
- 1988-11-12 CN CN88108806A patent/CN1015826B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3887638D1 (en) | 1994-03-17 |
| CN1015826B (en) | 1992-03-11 |
| EP0316745B1 (en) | 1994-02-02 |
| RU2093064C1 (en) | 1997-10-20 |
| US5054916A (en) | 1991-10-08 |
| CN1039115A (en) | 1990-01-24 |
| KR890008561A (en) | 1989-07-12 |
| KR910002652B1 (en) | 1991-04-27 |
| DE3887638T2 (en) | 1994-05-11 |
| JPH0569539B2 (en) | 1993-10-01 |
| EP0316745A1 (en) | 1989-05-24 |
| JPH01129838A (en) | 1989-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0399482B1 (en) | Liver function testing apparatus | |
| US5154176A (en) | Liver function testing apparatus | |
| CA1086982A (en) | Catheter oximeter apparatus and method | |
| JP3270917B2 (en) | Oxygen saturation measuring device, blood light absorbing substance concentration measuring device, and biological signal processing method | |
| CA1327401C (en) | Liver function testing apparatus | |
| JPS622809B2 (en) | ||
| EP0316812B1 (en) | Liver function testing apparatus | |
| Mignani et al. | In-vivo biomedical monitoring by fiber-optic systems | |
| US4905703A (en) | Liver function testing apparatus and method | |
| EP0276477B1 (en) | Apparatus for measuring the change in the concentration of a pigment in blood | |
| JPH0534979B2 (en) | ||
| JPH01129837A (en) | Liver function examination apparatus | |
| JPH0570467B2 (en) | ||
| JPH04336057A (en) | Liver function inspection device | |
| JPH0351177B2 (en) | ||
| JPH0534978B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |